744991
Last Update Posted: 2020-10-19
Recruiting has ended
All Genders accepted | 18 Years + |
25 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma
The purpose of the study is to determine the efficacy and safety of enzastaurin in participants with Cutaneous T-Cell Lymphoma (CTCL) who failed prior therapies.
Eligibility
Relevant conditions:
Cutaneous T-Cell Lymphoma
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov